Eli Lilly & Co. vs 3M Company
LLY vs MMM — side-by-side comparison from reported financials. LLY leads 8, MMM leads 3 of 11 comparable metrics.
Eli Lilly & Co.
LLY · Healthcare
$1 177.20+0.65%Solid
3M Company
MMM · Healthcare
$160.20-2.07%Mixed
| Metric | LLY | MMM |
|---|---|---|
| Price | $1 177.20 | $160.20 |
| Market cap | $1.05T | $82.6B |
| Revenue (TTM) | $79.7B | $25.2B |
| Revenue growth | +31.7% | -1.6% |
| Net margin | 33.5% | 11.9% |
| Free cash flow | $18.2B | $3.98B |
| Net cash (debt) | ($35.2B) | ($4.67B) |
| 1-year price return | +37.6% | +4.8% |
| P/E | 41.6 | 27.5 |
| P/E vs own history (cheap-side %) | 88% | 18% |
| Dividend yield | 0.52% | 1.93% |
| Return on equity | 93% | 77% |
| Altman Z-score | 7.10 | — |
| CV checks passed | 11 of 11 | 9 of 11 |
| Employees | 50,000 | 60,500 |
Full résumé-style profiles: LLY CV · MMM CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.